Brilacidin works in viruses by molecular docking to key proteins and interfering with a viruses replication. A vaccine works by stimulating the bodies immune system to recognize a particular virus.
Suddenly it seem pharma is producing Ivermectin, doxycycline and other 6LU7 docking drugs, however none have the broad spectral capabilities Brilacidin. It looks like they are switching to the main protease inhibitor side. I feel vindicated as Brilacidin was the right choice all along!
"Imitation is the highest form of flattery" (Oscar Wilde)